UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000033504 |
|---|---|
| Receipt number | R000038203 |
| Scientific Title | An uncontrolled open-label study on the efficacy and safety of sirolimus for epileptic seizures associated with focal cortical dysplasia type-II |
| Date of disclosure of the study information | 2018/07/25 |
| Last modified on | 2021/08/11 14:37:47 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2018/07/25 09:58:28 | ||
| 2 | Update | 2018/07/25 10:00:08 | UMIN ID1 |
|
| 3 | Update | 2018/10/15 11:35:03 | Recruitment status |
|
| 4 | Update | 2019/12/23 11:02:11 | Recruitment status Date of IRB |
|
| 5 | Update | 2020/07/27 11:04:04 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Organization Organization Address Address Tel |
|
| 6 | Update | 2020/07/27 11:09:05 | Number of participants that the trial has enrolled |
|
| 7 | Update | 2021/02/10 15:08:05 | UMIN ID2 |
|
| 8 | Update | 2021/08/04 09:27:11 | UMIN ID3 |
|
| 9 | Update | 2021/08/04 10:06:52 | Recruitment status Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 10 | Update | 2021/08/11 14:37:47 | UMIN ID1 |
